Variable | n = 49 |
---|---|
Demographics | |
Median age, y | 65 (54–74) |
Female sex | 14 (29%) |
Previous medical history | |
Diabetes mellitus | 6 (12%) |
Hypertension | 12 (24%) |
Cardiac disease | 12 (24%) |
Pre- existing therapy | 24 (49%) |
Clinical data | |
APACHE II | 24 (19–29) |
SOFA score | 11 (9–13) |
Mechanical ventilation,% | 90 |
Biochemical markers | |
Creatinine, μmol/l | 155 (92.0-231.0) |
Lactate, mmol/l | 2.3 (1.6-3.3) |
hsTNT, ng/l | 80 (24.0-193.5) |
BNP, pmol/l | 189 (107–375) |
Echocardiographic data | n = 46 |
LVEF,% | 45 (40–55) |
La volume, ml/m2 | 24 (21.0-31.6) |
AVPDm, mm | 10.7 (8.0-12.7) |
E, cm/s | 89 (71–104) |
A, cm/s | 67 (52–91) |
E/A | 1.3 (0.9-1.5) |
DT, ms | 165 (148–200) |
TDIs, cm/s | 8.6 (7.1-10.0) |
é, cm/s | 8.4 (7.1-10.0) |
á, cm/s | 9 (7.5- 12.3) |
E/é | 10.1 (8.5-12.2) |
LVOT VTI, cm | 17 (15–23) |
Mortality | |
7 day mortality,% | 16 |
28 day mortality,% | 27 |
1 year mortality,% | 37 |
ICU mortality,% | 27 |